This enhances STAT1 phosphorylation and activates the IFNγ-STAT1-IRF1-MHC class I antigen-presentation pathway, which ultimately leads to increased CD8+ T cell infiltration and suppression of tumor growth, independently of β-catenin (summarized in Supplementary information, Fig. S10a, b). The gene discussed is CD8A; the disease is neoplasm.